Skip to main content

Olink Inks Finland Distribution Pact

NEW YORK (GenomeWeb news) – Olink Bioscience said today that it has signed up Immuno Diagnostic to distribute its in situ protein detection systems in Finland.

Under the agreement, the Finnish company Immuno Diagnostic will distribute the Duolink in situ PLA product line, which is a proximity ligation assay technology that is used to detect proteins and their interactions and modifications. The technology allows for detection of target proteins with single-molecule resolution, Uppsala, Sweden-based Olink said.

"We see a great potential market for the PLA technology in the areas of academic and industrial research in Finland," Immuno Diagnostic's Sales Director and VP, Marko Laine, said in a statement.

Financial terms of the agreement were not released.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.